This webinar, moderated by Patrick Short, CEO and co-founder of Sano Genetics, and featuring two panelists, Jessi Keavney and Krista Qualmann, discussed the imp...
Continue reading
Clinical trials depend on sustained patient participation, yet recruitment shortfalls and early withdrawals remain two of the most common causes of trial delays...
Continue reading
Electronic consent, or e-consent, is a method of obtaining informed consent through an electronic system rather than a paper form. It typically incorporates mul...
Continue reading
Recently, our team was honoured to attend the World Orphan Drug Congress USA in Boston. The event brought together key stakeholders, experts, and industry leade...
Continue reading
Clinical trials are the foundation of modern medicine. They determine which treatments reach patients and how those treatments are understood. Yet for much of h...
Continue reading
As the landscape of healthcare and technology continues to evolve, clinical trials are undergoing significant transformations. In our latest trend report, we de...
Continue reading
Parkinson's disease (PD) is a complex neurodegenerative disorder driven by a combination of genetic and environmental factors. While most cases cannot be attrib...
Continue reading
Clinical trial populations consistently fail to reflect the demographics of the populations most affected by the diseases being studied. This gap is not simply ...
Continue reading
In precision medicine trials, DNA sequencing is not a background step. It determines eligibility, shapes enrollment pathways, and directly influences the qualit...
Continue reading
In genetically stratified trials, patient recruitment is structurally harder than in conventional studies. Eligibility depends not just on clinical diagnosis, b...
Continue reading